On November 18, 2026, the White House withdrew Dr. Heidi Overton’s nomination to lead the Food and Drug Administration just ahead of an anticipated Senate committee vote, according to NPR.
Overton was set to face a key vote on Wednesday in the Senate health committee, where Republicans hold only a one-vote majority. NPR reported that the White House pulled the nomination because she did not have the votes needed to be confirmed.
Cassidy Believed Overton Would Clear Committee
Senator Bill Cassidy, chair of the Senate health committee, stated on CBS’s “Face The Nation” that he was having productive conversations with committee members and believed Overton would have cleared his committee. Cassidy wrote that the final hangup was anti-abortion senators seeking assurances from the administration about its commitment to life issues, Techdirt reported.
“My conversations with her convinced me she would follow the science and push back against decisions that put Americans’ health at risk,” Cassidy wrote, according to Techdirt. “The Administration withdrew Dr. Overton rather than make such commitments.”
An anti-abortion rights group called Susan B. Anthony Pro-Life America urged legislators to delay the vote until the administration eliminates mail-order access to the abortion pill mifepristone, NPR reported. Overton was noncommittal during her September Senate hearing when questioned on the matter.
The White House pulls Dr. Heidi Overton’s nomination to lead the FDA amid growing concerns she didn’t have the votes to win Senate approval. https://t.co/CAtmQCO9Vh
Means Alleged Overton Relaxed Vape Standards
Techdirt reported that former Kennedy senior adviser Calley Means alleged this month that Overton wrote a policy relaxing standards for fruit-flavored vapes. Means also alleged that Overton helped the Justice Department construct a legal argument for why the Supreme Court should take up a case involving Bayer and its pesticide products.
Physicians and consumer advocates also opposed the nomination over public health stances. Dr. Robert Steinbrook, health research group director at Public Citizen, told NPR that Overton’s lack of managerial experience alone should be disqualifying.
“Even if her record was strong on public health and protecting the integrity of the FDA, which it is not, her lack of managerial experience alone should be disqualifying., said Robert Steinbrook, health research group director at Public Citizen.”
Emergency room physician Rob Davidson told NPR that Overton shares blame for a measles outbreak due to her work on executive orders changing childhood vaccine schedules.
“She was one of the chief architects. She’s been by his side sort of as his public health expert in the room, helping them shape all of this., said Rob Davidson, emergency room physician and executive director of the Committee to Protect Healthcare.”
Acting Commissioner Nears 210-Day Legal Limit
Kyle Diamantas has served as Acting Commissioner since May following the resignation of Dr. Marty Makary, who left after a tumultuous 13 months leading the agency, NPR reported. The Federal Vacancies Reform Act limits an acting commissioner’s service to 210 days, and Diamantas is currently just shy of 200 days in the role.
The White House said Tuesday it has pulled the nomination of Dr. Heidi Overton to lead the Food and Drug Administration amid growing indications she didn't have the votes needed to win Senate confirmation. https://t.co/nus5y4MTsR
Cassidy said that confirming a permanent commissioner will now likely fall to Senate Democrats given the limited time left, Techdirt reported.
Born in 1989 in Cortez, Colorado, Dr. Heidi Overton graduated from the University of New Mexico School of Medicine in 2015 before completing residency training at Johns Hopkins Hospital. She later served as a White House fellow and directed the healthcare policy team at the America First Policy Institute before becoming the deputy assistant to the president for domestic policy in the second Trump administration.
The FDA employs 18,000 workers to regulate food, medicines, medical devices, and tobacco, with no confirmed leader since Makary’s departure, according to NPR.
More on White House
The White House has pulled Dr. Heidi Overton's nomination to lead the FDA in the face of Senate opposition to her candidacy, a White House official confirmed. https://t.co/1bGWGjEke1
Breaking news: The White House is abandoning the nomination of Heidi Overton to lead the FDA amid growing concerns that she could not be confirmed by the Senate. https://t.co/JWHZ1WjVpd
Dr. Heidi Overton’s nomination to lead the Food and Drug Administration was dropped on Tuesday, a White House official confirmed to ABC News. Read more: https://t.co/oobI2rEEGl pic.twitter.com/YPSdHLwlNO
Worth a look
- MIT Study Finds Brain Fluid Waves Weaken With Age
- Grand Theft Auto VI Mania Strains Relationships
- Senate Republicans Poised to Block Trump Pentagon Nominees (time.news)
- University of Iowa Researchers Mobilize Independent Lead Monitoring Ahead of Monday Detonation at Iowa Army Ammunition Plant (news-usa.today)